SIC 5912 – Drug Stores and Proprietary Stores
| Valuation | |
|---|---|
| Market Cap ($M) | 81,918.49 |
| Enterprise Value ($M) | 147,969.86 |
| Book Value ($M) | 59,686.00 |
| Book Value / Share | 45.94 |
| Price / Book | 1.37 |
| NCAV ($M) | -111,905.00 |
| NCAV / Share | -86.14 |
| Price / NCAV | -0.73 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.00 |
| Return on Assets (ROA) | -0.01 |
| Return on Equity (ROE) | -0.02 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.64 |
| Current Ratio | 0.95 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 47,857.00 |
| Assets | 219,768.00 |
| Liabilities | 159,762.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 194,579.00 |
| Operating Income | 4,021.00 |
| Net Income | -596.00 |
| Earnings Per Share Basic | -0.57 |
| Earnings Per Share Diluted | -0.57 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 8,865.00 |
| Cash from Investing | -43,285.00 |
| Cash from Financing | -43,285.00 |
Source: Fintel.io |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 8.44 | 38.99 | |
| 13G/A | BlackRock Inc. | 7.30 | 40.00 | |
| 13G/A | FMR LLC / Fidelity | 4.52 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
Source: Fintel.io |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
Source: Fintel.io |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| CVS / CVS Health Corporation 10-Q – Quarterly Report – 10-Q | ||
| CVS / CVS Health Corporation 10-Q Quarterly Report 10-Q | ||
| CVS / CVS Health Corporation FORM 10-K (Annual Report) | ||
| CVS / CVS Health Corporation 10-Q (Quarterly Report) | ||
Source: Fintel.io |
||
| Similar Companies | |
|---|---|
| DPLO – Diplomat Pharmacy, Inc. | PMC – PharMerica Corp. |
| RAD – Rite Aid Corp. |
Financial data and stock pages provided by
Fintel.io